Evidence map›Paper›PMID 24646103›Full record

ArticleThe Journal of clinical endocrinology and metabolism2014

A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia.

Nadia Schoenmakers, Carla Moran, Irene Campi, Maura Agostini, Olivia Bacon, Odelia Rajanayagam, John Schwabe, Sonia Bradbury, Timothy Barrett, Frank Geoghegan and 9 more

Erratum issuedOpen access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. A 2019 update on TSH-secreting pituitary adenomas.Journal of endocrinological investigation · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Central hypothyroidism - a neglected thyroid disorder.Nature reviews. Endocrinology · 2017
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Inherited defects of thyroxine-binding proteins.Best practice & research. Clinical endocrinology & metabolism · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 2 countries.

Nadia SchoenmakersUniversity of Cambridge Metabolic Research Laboratories (N.S., C.M., M.A., O.R., G.L., M.G., K.C.), Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Institute of Endocrine Sciences (I.C., P.B.-P.), University of Milan, 20132 Milan, Italy; Department of Biochemistry (J.S.), University of Leicester, Leicester LE1 7RH, United Kingdom; Departments of Paediatrics (T.B.) and Clinical Chemistry (M.B.), Birmingham Childrens Hospital, Birmingham B15 2TT, United Kingdom; Departments of Endocrinology (M.D.), St Bartholomew's Hospital, London E1 4NS, United Kingdom; Department of Clinical Biochemistry (F.G.), Ealing Hospital, London UB1 3EU, United Kingdom; Department of Clinical Biochemistry (A.O., P.C.), Selly Oak Hospital, Birmingham B29 6JD, United Kingdom; and Department of Clinical Biochemistry (O.B., S.B., D.H.), Addenbrooke's Hospital, Cambridge CB2 2OO, United Kingdom.
Carla Moran
Irene Campi
Maura Agostini
Olivia Bacon
Odelia Rajanayagam
John Schwabe
Sonia Bradbury
Timothy Barrett
Frank Geoghegan
Maralyn Druce
Paolo Beck-Peccoz
Angela O'Toole
Penelope Clark
Michelle Bignell
Greta Lyons
David Halsall
Mark Gurnell
Krishna Chatterjee
Addenbrooke's Hospital · GBWellcome/MRC Institute of Metabolic Science · GBMedical Research Council · GBSelly Oak Hospital · GBUniversity of Milan · ITBirmingham Children's Hospital · GBEaling Hospital · GBSt Bartholomew's Hospital · GBUniversity of Birmingham · GBUniversity of Cambridge · GBUniversity of Leicester · GB

Funding

Medical Research Council G0600717Wellcome Trust 095564Wellcome Trust 095564/Z/11/ZWellcome Trust 100237Wellcome Trust 100574Wellcome Trust 100585/Z/12/Z
6 · The paper itself

Abstract

contextFamilial dysalbuminemic hyperthyroxinemia, characterized by abnormal circulating albumin with increased T4 affinity, causes artefactual elevation of free T4 concentrations in euthyroid individuals.

objectiveFour unrelated index cases with discordant thyroid function tests in different assay platforms were investigated. DESIGN AND

resultsLaboratory biochemical assessment, radiolabeled T4 binding studies, and ALB sequencing were undertaken. (125)I-T4 binding to both serum and albumin in affected individuals was markedly increased, comparable with known familial dysalbuminemic hyperthyroxinemia cases. Sequencing showed heterozygosity for a novel ALB mutation (arginine to isoleucine at codon 222, R222I) in all four cases and segregation of the genetic defect with abnormal biochemical phenotype in one family. Molecular modeling indicates that arginine 222 is located within a high-affinity T4 binding site in albumin, with substitution by isoleucine, which has a smaller side chain predicted to reduce steric hindrance, thereby facilitating T4 and rT3 binding. When tested in current immunoassays, serum free T4 values from R222I heterozygotes were more measurably abnormal in one-step vs two-step assay architectures. Total rT3 measurements were also abnormally elevated.

conclusionsA novel mutation (R222I) in the ALB gene mediates dominantly inherited dysalbuminemic hyperthyroxinemia. Susceptibility of current free T4 immunoassays to interference by this mutant albumin suggests likely future identification of individuals with this variant binding protein.

Indexed as

Mutation, MissenseAdultAmino Acid SubstitutionArginineChild, PreschoolFemaleHumansHyperthyroxinemia, Familial DysalbuminemicIsoleucineMaleModels, MolecularPrealbuminThyroid Function TestsYoung AdultArginineIsoleucinePrealbumin

Identifiers

PMID24646103
PMCPMC4191552
OpenAlexW2027758414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.